Recombinant Human WISP2 Protein，His

WISP2, or WNT1 inducible signaling pathway protein 2, is a member of the CCN family of secreted proteins, which play critical roles in cellular processes such as proliferation, differentiation, and migration. Researchers have focused on WISP2 due to its involvement in various physiological and pathological conditions, including cancer, fibrosis, and bone disorders. It is believed to modulate signaling pathways associated with Wnt and TGF-β, thereby influencing tissue development and repair. Studies have indicated that aberrant expression of WISP2 is linked to tumor progression and metastasis, highlighting its potential as a biomarker and therapeutic target in oncology. Recent investigations utilizing recombinant WISP2 proteins have provided insights into its functional mechanisms and interactions with cellular receptors, offering a deeper understanding of its role in cellular signaling. Furthermore, the production of recombinant WISP2 has facilitated the exploration of its structure-function relationships, advancing the knowledge of its biological activity. This research is poised to contribute to the development of novel treatment strategies targeting WISP2-related pathways, with the hope of improving outcomes in diseases where WISP2 plays a critical role. As the scientific community continues to unravel the complexities of WISP2, its potential as a therapeutic agent and a valuable tool in understanding cellular dynamics remains an exciting area of exploration.